For the year ending 2025-12-31, HLYK had -$39,105 decrease in cash & cash equivalents over the period. -$1,713,810 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Proceeds from sale of assets of btg business | 125,000 |
| Proceeds from sale of aco business | 0 |
| Acquisition of property and equipment | 0 |
| Net cash used in investing activities | 125,000 |
| Proceeds from related party notes payable and advances | 1,609,840 |
| Proceeds from third party notes payable | 630,000 |
| Repayment of related party notes payable and advances | 136,000 |
| Repayment of third party notes payable | 584,135 |
| Proceeds from sale of common stock | 30,000 |
| Net cash provided by financing activities | 1,549,705 |
| Depreciation and amortization | 101,871 |
| Stock based compensation, including amortization of deferred equity compensation | 158,625 |
| Gain on change in fair value of derivative financial instruments | 8,644 |
| Change in fair value of debt | -618,208 |
| Inventory | -26,724 |
| Contract assets | -20,058 |
| Prepaid expenses and other current assets | -47,866 |
| Right of use lease assets | 183,229 |
| Accounts payable and accrued expenses | 424,365 |
| Lease liability | -184,261 |
| Contract liabilities | -162,899 |
| Net loss | -3,280,254 |
| Gain on sale of assets | 168,722 |
| (gain) loss on extinguishment of debt | 317,982 |
| Amortization of debt discount | 828,006 |
| Impairment loss | 0 |
| Other non-cash adjustments | 0 |
| Accounts receivable | 0 |
| Gain from realization of contingent sale consideration receivable | 0 |
| Net cash used in operating activities | -1,713,810 |
| Net decrease in cash | -39,105 |
| Cash, beginning of period | 76,241 |
| Cash, end of period | 37,136 |
HealthLynked Corp (HLYK)
HealthLynked Corp (HLYK)